Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 4, 2011, Pages 278-284

  Wang, Lin ^a   Wang, Hui ^a   Ye, Jue ^a   Xu, Rui Xia ^a   Song, Li ^a   Shi, Na ^a   Zhang, Yan Wan ^a   Chen, Xi ^a   Meng, Xian Min ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiomyocyte; Endothelin 1; Hypertrophy; Troponin I interacting kinase

Indexed keywords

ADENOVIRUS VECTOR; ENDOTHELIN 1; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; PHOSPHOTRANSFERASE; TROPONIN I INTERACTING KINASE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL SURFACE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HEART MUSCLE CELL; MUSCLE HYPERTROPHY; NONHUMAN; RAT; SARCOMERE; UPREGULATION;

ADENOVIRIDAE; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; ENDOTHELIN-1; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HUMANS; LEUCINE; MAP KINASE KINASE KINASES; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SARCOMERES; VENTRICULAR MYOSINS;

EID: 79953043643     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05499.x     Document Type: Article

References (29)

1. Rame JE, Dries DL. Heart failure and cardiac hypertrophy. Curr. Treat. Options Cardiovasc. Med. 2007; 9: 289-301.
2. Frey N, Olson EN. Cardiac hypertrophy: The good, the bad, and the ugly. Annu. Rev. Physiol. 2003; 65: 45-79.
3. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development 2007; 134: 4131-40.
4. White DE, Coutu P, Shi YF et al. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev. 2006; 20: 2355-60.
5. Garciarena CD, Pinilla OA, Nolly MB et al. Endurance training in the spontaneously hypertensive rat: Conversion of pathological into physiological cardiac hypertrophy. Hypertension 2009; 53: 708-14.
6. Kozma SC, Thomas G. Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays 2002; 24: 65-71.
7. Wang H, Chen C, Song X et al. Mef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene. J. Cell Mol. Med. 2008; 12: 304-15.
8. Zhao Y, Meng XM, Wei YJ et al. Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J. Mol. Med. 2003; 81: 297-304.
9. Rosano L, Spinella F, Di Castro V et al. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol. Cancer Ther. 2006; 5: 833-42.
10. Hannigan GE, Coles JG, Dedhar S. Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ. Res. 2007; 100: 1408-14.
11. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912-34.
12. Feng Y, Cao HQ, Liu Z, Ding JF, Meng XM. Identification of the dual specificity and the functional domains of the cardiac-specific protein kinase TNNI3K. Gen. Physiol. Biophys. 2007; 26: 104-9.
13. Feng Y, Liu DQ, Wang Z et al. AOP-1 interacts with cardiac-specific protein kinase TNNI3K and down-regulates its kinase activity. Biochemistry (Mosc) 2007; 72: 1199-204.
14. Lai ZF, Chen YZ, Feng LP et al. Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H708-16.
15. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. USA 2002; 99: 12825-30.
16. Hirotani S, Otsu K, Nishida K et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002; 105: 509-15.
17. Lan CC, Tang R, Un San Leong I, Love DR. Quantitative real-time RT-PCR (qRT-PCR) of zebrafish transcripts: optimization of RNA extraction, quality control considerations, and data analysis. CSH Protoc. 2009; 2009: pdb.prot5314.
18. Morgan HE, Baker KM. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 1991; 83: 13-25.
19. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am. J. Hypertens. 2001; 14: 83S-9S.
20. Knowlton KU, Baracchini E, Ross RS et al. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J. Biol. Chem. 1991; 266: 7759-68.
21. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides 2005; 26: 944-56.
22. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001; 20: 2401-12.
23. Herron TJ, McDonald KS. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ. Res. 2002; 90: 1150-2.
24. Korte FS, Herron TJ, Rovetto MJ, McDonald KS. Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts. Am. J. Physiol. Heart Circ. Physiol. 2005; 289: H801-12.
25. Gupta MP. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J. Mol. Cell. Cardiol. 2007; 43: 388-403.
26. Leslie NR, Biondi RM, Alessi DR. Phosphoinositide-regulated kinases and phosphoinositide phosphatases. Chem. Rev. 2001; 101: 2365-80.
27. Bogoyevitch MA, Ketterman AJ, Sugden PH. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J. Biol. Chem. 1995; 270: 29710-17.
28. Clerk A, Michael A, Sugden PH. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J. Cell Biol. 1998; 142: 523-35.
29. Wheeler FC, Tang H, Marks OA et al. Tnni3k modifies disease progression in murine models of cardiomyopathy. PLoS Genet. 2009; 5: e1000647.